{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:03:22Z","timestamp":1784865802826,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to assess the epidemiological changes in breast, cervical, colon, and rectal cancers in Kazakhstan before and during COVID-19, including early-onset cancer (EOC) diagnosed between the ages of 20 and 49, using data from the oncological service of the Republic of Kazakhstan for the 2017\u20132022 period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The cohort comprised patients aged 20 to 49 years (EOC) and 50 years and older [late-onset cancer (LOC)] from the total number of patients diagnosed each year during the study period of 2017 to 2022 for breast, cervical, colon, or rectal cancer. In order to indicate a difference in one-time intervals and characterize the global trend over the entire study period, annual percentage change (APC) and average APC (AAPC) were calculated, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Breast cancer detection rates increased by 22.8% for EOC and 15.9% for LOC from 2017 to 2022, and AAPC increased by 4.3% for EOC and 3.6% for LOC. During the COVID-19 restriction period, breast cancer detection rates decreased by 6.1% for EOC and 15.6% for LOC. Cervical cancer detection rates increased by 2.3% for EOC and 7.5% for LOC from 2017 to 2022, and AAPC increased by 0.9% for EOC and 1.6% for LOC. During the COVID-19 restriction period, cervical cancer detection rates decreased by 11.3% for EOC and 3.1% for LOC. Colon cancer detection rates increased by 18.4% for EOC and 14.3% for LOC from 2017 to 2022, and AAPC increased by 3.7% for EOC and 2.9% for LOC. During the COVID-19 restriction period, colon cancer detection rates decreased by 14.4% for EOC and 5.8% for LOC. Rectal cancer detection rates increased by 13.6% for EOC and 19.2% for LOC from 2017 to 2022, and AAPC increased by 3.0% for EOC and by 3.9% for LOC. During the COVID-19 restriction period, rectal cancer detection rates increased by 18.6% for EOC and decreased by 12.0% for LOC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The epidemiological indicators of population cancer screening worsened during the COVID pandemic; the detection rate decreased by 6.1% for breast EOC and 11.3% for cervical EOC, while there was an increase by 38.0% in EOC for colon cancer in men and by 8.0% in EOC for rectal cancer in men and 31.1% in women.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1481242","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:12:36Z","timestamp":1738231956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 pandemic shifted epidemiology for cancer screening sites: breast, cervix, colon, and rectum"],"prefix":"10.3389","volume":"14","author":[{"given":"Yevgeniy","family":"Ishkinin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilyara","family":"Kaidarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serzhan","family":"Nazarbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Zhylkaidarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniya","family":"Ossikbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Mussina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazgul","family":"Omarbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/00031348221087920","article-title":"Impact of the COVID-19 pandemic on breast cancer screening and operative treatment","volume":"88","author":"Cairns","year":"2022","journal-title":"Am Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1182170","article-title":"Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020","volume":"13","author":"Kiss","year":"2023","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85680","article-title":"A rapid review of COVID-19\u2019s global impact on breast cancer screening participation rates and volumes from January to December 2020","volume":"12","author":"Lee","year":"2023","journal-title":"eLife"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.e13601","article-title":"Effect of digital technologies on mammographic screening in the Republic of Kazakhstan","volume":"39","author":"Saktaganov","year":"2021","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"106596","DOI":"10.1016\/j.ypmed.2021.106596","article-title":"Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities","volume":"151","author":"Wentzensen","year":"2021","journal-title":"Prev Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-021-00679-x","article-title":"Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review","volume":"53","author":"Mazidimoradi","year":"2022","journal-title":"J Gastrointest Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2019.198","article-title":"Trends of colorectal cancer prevalence in Kazakhstan related to screening","volume":"54","author":"Zhylkaidarova","year":"2020","journal-title":"Clin Endosc"},{"key":"B10","unstructured":"Epic Research\n          Delayed cancer screenings"},{"key":"B11","unstructured":"Website Mast\n              C\n            \n            \n              Deckert\n              J\n            \n            \n              del R\u00edo\n              AM\n            \n          \n          Epic Research\n          Troubling cancer screening rates still seen nearly two years into the pandemic"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2021.11.025","article-title":"Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review","volume":"82","author":"Tsapatsaris","year":"2022","journal-title":"Clin Imaging"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102212","article-title":"Colonoscopy screening and surveillance disparities during the COVID-19 pandemic","volume":"80","author":"Randle","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33128","article-title":"Cancer screenings decline significantly during pandemic","volume":"126","author":"Printz","year":"2020","journal-title":"Cancer"},{"key":"B15","first-page":"1","volume-title":"Age standardization of rates: a new WHO standard","author":"Ahmad","year":"2001"},{"key":"B16","first-page":"209","volume-title":"Indicators of the oncology service of the Republic of Kazakhstan, 2018 (statistical and analytical materials)","author":"Kaidarova","year":"2019"},{"key":"B17","first-page":"225","volume-title":"Indicators of the oncology service of the Republic of Kazakhstan, 2019 (statistical and analytical materials)","author":"Kaidarova","year":"2020"},{"key":"B18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.52532\/978-601-7548-11-7-2020-1-370","volume-title":"Indicators of the oncology service of the Republic of Kazakhstan, 2020 (statistical and analytical materials)","author":"Kaidarova","year":"2021"},{"key":"B19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.52532\/1-11-2021-1-384","volume-title":"Indicators of the oncology service of the Republic of Kazakhstan, 2021 (statistical and analytical materials)","author":"Kaidarova","year":"2022"},{"key":"B20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.52532\/1-09-2023-1-430","volume-title":"Indicators of the oncology service of the Republic of Kazakhstan, 2022 (statistical and analytical materials)","author":"Kaidarova","year":"2023"},{"key":"B21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12885-019-5787-x","article-title":"Cancer stigma and cancer screening attendance: a population based survey in England","volume":"19","author":"Vrinten","year":"2019","journal-title":"BMC Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","article-title":"A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis","volume":"67","author":"Li","year":"2023","journal-title":"Breast"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.43796","article-title":"Cancer screening disparities before and after the COVID-19 pandemic","volume":"6","author":"Lofters","year":"2023","journal-title":"JAMA Network Open"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02791-8","article-title":"Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland \u2013 a scoping review","volume":"131","author":"Lohfeld","year":"2024","journal-title":"Br J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86562.sa2","article-title":"The impact of COVID-19 on cancer screening and treatment in older adults: The Multiethnic Cohort Study","volume":"12","author":"Mak","year":"2023","journal-title":"Elife"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81605.sa2","article-title":"Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study","volume":"12","author":"Nonboe","year":"2023","journal-title":"eLife"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43119","article-title":"Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy","volume":"5","author":"Rottoli","year":"2022","journal-title":"JAMA Network Open"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04707-0","article-title":"Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany","volume":"149","author":"Voigtl\u00e4nder","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.5.1781","article-title":"HPV vaccination and cervical cancer screening policies and practices in 18 countries, territories and entities across eastern europe and central asia","volume":"24","author":"Davies","year":"2023","journal-title":"Asian Pac J Cancer Prevention: APJCP"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1481242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:12:43Z","timestamp":1738231963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1481242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":30,"alternative-id":["10.3389\/fonc.2024.1481242"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1481242","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"article-number":"1481242"}}